OCGN

Ocugen Stock Price

0.2173
0.0009 (0.42%)
Upgrade to Real-Time
Afterhours (Closed)
0.2164
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Ocugen Inc OCGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0036 -1.64% 0.2164 0.2134 0.2299 0.2214 0.22 00:00:05
Bid Price Ask Price Spread Spread % News
0.21 0.22 0.01 4.55% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,981 5,765,681 $ 0.2179413 $ 1,256,580 14,828,376 0.17 - 3.35
Last Trade Time Type Quantity Stock Price Currency
19:59:40 formt 5,625 $ 0.2173 USD

Ocugen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 23.85M 110.22M 105.05M $ - $ - -8.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 75.00k 2.50%

more financials information »

Ocugen News

Date Time Source News Article
6/16/202008:46Edgar (US Regulatory)Current Report Filing (8-k)
6/12/202016:36Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/12/202016:31Edgar (US Regulatory)Current Report Filing (8-k)
6/03/202016:33Edgar (US Regulatory)Current Report Filing (8-k)
6/03/202008:30GlobeNewswire Inc.Ocugen Appoints Dr. Mohamed Genead as Chair of Retina..
6/01/202009:23Edgar (US Regulatory)Current Report Filing (8-k)
6/01/202009:20GlobeNewswire Inc.Ocugen to Discontinue Phase 3 oGVHD Trial
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OCGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.220.2450.200.21334357,006,754-0.0036-1.64%
1 Month0.270.320.200.240117211,382,690-0.0536-19.85%
3 Months0.440.49980.170.276003910,748,255-0.2236-50.82%
6 Months0.6750.83880.170.33845336,691,815-0.4586-67.94%
1 Year3.243.350.170.44626596,524,002-3.02-93.32%
3 Years3.243.350.170.44626596,524,002-3.02-93.32%
5 Years3.243.350.170.44626596,524,002-3.02-93.32%

Ocugen Description

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).
Your Recent History
NASDAQ
OCGN
Ocugen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200711 23:02:24